人工智能驱动的疾病检测领域的领导者Viz.ai宣布了与精准肿瘤公司Guardant Health的合作计划,以改善肺癌护理。目标是帮助肿瘤学家更早地诊断肺癌,并做出更明智的治疗决策,这反映了他们共同致力于使用技术改善癌症护理。该合作旨在通过Guardant360®CDx液体活检促进及时的生物标志物检测,加速精确诊断和最佳治疗选择,从而解决肺癌患者旅程中的差距。这反映了ai向肿瘤学的扩展,利用ai和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.